Atrys Health - Public Comps and Valuation Multiples

Atrys Health Overview

About Atrys Health

Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Founded

2007

HQ

Employees

Website

atryshealth.com

Sectors

Medical Imaging & Diagnostics
Telemedicine & Virtual Care
BioTech
HealthTech

Financials

LTM Revenue $264M

LTM EBITDA $54.7M

EV

$513M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Atrys Health Financials

As of November 2025, Atrys Health reported last 12-month revenue of $264M and EBITDA of $54.7M.

In the same period, Atrys Health generated $174M in LTM gross profit and -$7.6M in net income.

See Atrys Health valuation multiples based on analyst estimates

Atrys Health P&L

In the most recent fiscal year, Atrys Health reported revenue of $247M and EBITDA of $22.2M.

Atrys Health expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Atrys Health valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$264M	XXX	$247M	XXX	XXX	XXX
Gross Profit	$174M	XXX	$169M	XXX	XXX	XXX
Gross Margin	66%	XXX	68%	XXX	XXX	XXX
EBITDA	$54.7M	XXX	$22.2M	XXX	XXX	XXX
EBITDA Margin	21%	XXX	9%	XXX	XXX	XXX
EBIT	$21.9M	XXX	$12.1M	XXX	XXX	XXX
EBIT Margin	8%	XXX	5%	XXX	XXX	XXX
Net Profit	-$7.6M	XXX	-$36.9M	XXX	XXX	XXX
Net Margin	-3%	XXX	-15%	XXX	XXX	XXX
Net Debt	XXX	XXX	$237M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Atrys Health including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $264M. EBITDA for the last twelve months was $54.7M. In the most recent fiscal year, Atrys Health achieved $247M in revenue and $22.2M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$264M	Analyst estimates available to subscribers	$247M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$174M	Analyst estimates available to subscribers	$169M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	65.9% gross margin	Analyst estimates available to subscribers	68.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$54.7M	Analyst estimates available to subscribers	$22.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	20.7% EBITDA margin	Analyst estimates available to subscribers	9.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$21.9M	Analyst estimates available to subscribers	$12.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	8.3% EBIT margin	Analyst estimates available to subscribers	4.9% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$7.6M	Analyst estimates available to subscribers	-$36.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-2.9% net profit margin	Analyst estimates available to subscribers	-14.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$237M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Atrys Health

This financial data table provides comprehensive performance metrics for Atrys Health, a company based in Spain. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Atrys Health generated $264M in revenue over the last twelve months.
The company achieved $54.7M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $174M.
Net income over the last twelve months reached -$7.6M.

Fiscal Year Performance

In the most recent fiscal year, Atrys Health reported $247M in total revenue.
Fiscal year EBITDA was $22.2M.
The company maintained a gross profit margin of 68.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was 9.0%.
Net profit margin reached -14.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Atrys Health. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Atrys Health Stock Performance

Atrys Health has current market cap of EUR 205M (or $238M), and EV of EUR 442M (or $513M).

Market Cap Evolution

Atrys Health Stock Data

As of December 4, 2025, Atrys Health's stock price is EUR 3 (or $3).

See Atrys Health trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$513M	$238M	XXX	XXX	XXX	XXX	$-0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Atrys Health Valuation Multiples

Atrys Health's trades at 2.1x EV/Revenue multiple, and 23.2x EV/EBITDA.

See valuation multiples for Atrys Health and 15K+ public comps

Atrys Health Financial Valuation Multiples

As of December 4, 2025, Atrys Health has market cap of $238M and EV of $513M.

Equity research analysts estimate Atrys Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Atrys Health has a P/E ratio of -31.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$238M	XXX	$238M	XXX	XXX	XXX
EV (current)	$513M	XXX	$513M	XXX	XXX	XXX
EV/Revenue	1.9x	XXX	2.1x	XXX	XXX	XXX
EV/EBITDA	9.4x	XXX	23.2x	XXX	XXX	XXX
EV/EBIT	23.4x	XXX	42.6x	XXX	XXX	XXX
EV/Gross Profit	3.0x	XXX	n/a	XXX	XXX	XXX
P/E	-31.5x	XXX	-6.5x	XXX	XXX	XXX
EV/FCF	42.6x	XXX	-43.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Atrys Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Atrys Health Margins & Growth Rates

Atrys Health's last 12 month revenue growth is -11%

Atrys Health's revenue per employee in the last FY averaged $4.0M, while opex per employee averaged $2.5M for the same period.

Atrys Health's rule of 40 is 3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Atrys Health's rule of X is -7% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Atrys Health and other 15K+ public comps

Atrys Health Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	-11%	XXX	-3%	XXX	XXX	XXX
EBITDA Margin	21%	XXX	9%	XXX	XXX	XXX
EBITDA Growth	-9%	XXX	27%	XXX	XXX	XXX
Rule of 40	3%	XXX	-2%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-7%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$4.0M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$2.5M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	63%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial